These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24970258)

  • 41. Pyrophosphorolysis-activated polymerization detects circulating tumor DNA in metastatic uveal melanoma.
    Madic J; Piperno-Neumann S; Servois V; Rampanou A; Milder M; Trouiller B; Gentien D; Saada S; Assayag F; Thuleau A; Nemati F; Decaudin D; Bidard FC; Desjardins L; Mariani P; Lantz O; Stern MH
    Clin Cancer Res; 2012 Jul; 18(14):3934-41. PubMed ID: 22645051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Isolation and enrichment of urologic tumor cells in blood samples by a semi-automated CD45 depletion autoMACS protocol.
    Meye A; Bilkenroth U; Schmidt U; Füssel S; Robel K; Melchior AM; Blümke K; Pinkert D; Bartel F; Linne C; Taubert H; Wirth MP
    Int J Oncol; 2002 Sep; 21(3):521-30. PubMed ID: 12168095
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liver function tests in metastatic uveal melanoma.
    Kaiserman I; Amer R; Pe'er J
    Am J Ophthalmol; 2004 Feb; 137(2):236-43. PubMed ID: 14962411
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical presentation, pathological features and natural course of metastatic uveal melanoma, an orphan and commonly fatal disease.
    Cerbone L; Van Ginderdeuren R; Van den Oord J; Fieuws S; Spileers W; Van Eenoo L; Wozniak A; Sternberg CN; Schöffski P
    Oncology; 2014; 86(3):185-9. PubMed ID: 24776955
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Application of immunomagnetic cell enrichment in combination with RT-PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood.
    Tong X; Yang L; Lang JC; Zborowski M; Chalmers JJ
    Cytometry B Clin Cytom; 2007 Sep; 72(5):310-23. PubMed ID: 17205568
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Isolation of circulating cancer cells from whole blood by immunomagnetic cell enrichment and unenriched immunocytochemistry in vitro.
    Zigeuner RE; Riesenberg R; Pohla H; Hofstetter A; Oberneder R
    J Urol; 2003 Feb; 169(2):701-5. PubMed ID: 12544346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carcinoembryonic antigen cell adhesion molecule-1 (CEACAM1) in posterior uveal melanoma: correlation with clinical and histological survival markers.
    Khatib N; Pe'er J; Ortenberg R; Schachter J; Frenkel S; Markel G; Amer R
    Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9368-72. PubMed ID: 22039239
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased HIF-1α expression correlates with cell proliferation and vascular markers CD31 and VEGF-A in uveal melanoma.
    Mouriaux F; Sanschagrin F; Diorio C; Landreville S; Comoz F; Petit E; Bernaudin M; Rousseau AP; Bergeron D; Morcos M
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1277-83. PubMed ID: 24481264
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CXC chemokine receptor 4 is expressed in uveal malignant melanoma and correlates with the epithelioid-mixed cell type.
    Scala S; Ieranò C; Ottaiano A; Franco R; La Mura A; Liguori G; Mascolo M; Staibano S; Ascierto PA; Botti G; De Rosa G; Castello G
    Cancer Immunol Immunother; 2007 Oct; 56(10):1589-95. PubMed ID: 17410362
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Melanoma inhibitory activity: a novel serum marker for uveal melanoma.
    Schaller UC; Bosserhoff AK; Neubauer AS; Buettner R; Kampik A; Mueller AJ
    Melanoma Res; 2002 Dec; 12(6):593-9. PubMed ID: 12459649
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Establishment and Characterization of Orthotopic Mouse Models for Human Uveal Melanoma Hepatic Colonization.
    Ozaki S; Vuyyuru R; Kageyama K; Terai M; Ohara M; Cheng H; Manser T; Mastrangelo MJ; Aplin AE; Sato T
    Am J Pathol; 2016 Jan; 186(1):43-56. PubMed ID: 26613897
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].
    Cai QQ; Huang HQ; Lin TX; Jiang WQ
    Ai Zheng; 2005 Jul; 24(7):837-41. PubMed ID: 16004811
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a molecular multimarker assay for the analysis of circulating tumor cells in adenocarcinoma patients.
    de Albuquerque A; Kubisch I; Ernst D; Breier G; Stamminger G; Fersis N; Stölzel U; Boese-Landgraf J; Eichler A; Kaul S
    Clin Lab; 2012; 58(5-6):373-84. PubMed ID: 22783565
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ME20-S as a Potential Biomarker for the Evaluation of Uveal Melanoma.
    Bande MF; Santiago M; Mera P; Piulats JM; Blanco MJ; Rodríguez-Álvarez MX; Capeans C; Piñeiro A; Pardo M
    Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7007-11. PubMed ID: 26523384
    [TBL] [Abstract][Full Text] [Related]  

  • 55. JARID1B protein expression and prognostic implications in uveal melanoma.
    Radberger P; Radberger A; Bykov VJ; Seregard S; Economou MA
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4442-9. PubMed ID: 22669717
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Overexpression of the KIT/SCF in uveal melanoma does not translate into clinical efficacy of imatinib mesylate.
    Hofmann UB; Kauczok-Vetter CS; Houben R; Becker JC
    Clin Cancer Res; 2009 Jan; 15(1):324-9. PubMed ID: 19118061
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circulating melanoma cells as a potential biomarker to detect metastasis and evaluate prognosis.
    Hida T; Yoneta A; Wakamatsu K; Yanagisawa K; Ishii-Osai Y; Kan Y; Kato J; Yamashita T
    Australas J Dermatol; 2016 May; 57(2):145-9. PubMed ID: 26931184
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic value of microphthalmia-associated transcription factor and tyrosinase as markers for circulating tumor cells detection in patients with melanoma.
    Samija I; Lukac J; Marić-Brozić J; Buljan M; Alajbeg I; Kovacević D; Situm M; Kusić Z
    Melanoma Res; 2010 Aug; 20(4):293-302. PubMed ID: 20357686
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proton therapy for uveal melanoma in 43 juvenile patients: long-term results.
    Petrovic A; Bergin C; Schalenbourg A; Goitein G; Zografos L
    Ophthalmology; 2014 Apr; 121(4):898-904. PubMed ID: 24405742
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of formalin-fixed and snap-frozen samples analyzed by multiplex ligation-dependent probe amplification for prognostic testing in uveal melanoma.
    Lake SL; Kalirai H; Dopierala J; Damato BE; Coupland SE
    Invest Ophthalmol Vis Sci; 2012 May; 53(6):2647-52. PubMed ID: 22427594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.